IDEXX Laboratories, Inc. (LON:0J8P)
London flag London · Delayed Price · Currency is GBP · Price in USD
507.94
+14.38 (2.91%)
At close: May 12, 2025

IDEXX Laboratories Revenue

IDEXX Laboratories had revenue of $998.43M USD in the quarter ending March 31, 2025, with 3.56% growth. This brings the company's revenue in the last twelve months to $3.93B, up 5.56% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.

Revenue (ttm)
$3.93B
Revenue Growth
+5.56%
P/S Ratio
10.19
Revenue / Employee
$357.44K
Employees
11,000
Market Cap
31.02B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.90B236.55M6.46%
Dec 31, 20233.66B293.63M8.72%
Dec 31, 20223.37B151.96M4.73%
Dec 31, 20213.22B508.71M18.79%
Dec 31, 20202.71B299.75M12.45%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings